Notch signaling and its role in breast cancer

Frontiers in Bioscience

Volumn 12, Issue 11, 2007, Pages 4370-7383

  Wu, Fangting ^a   Stutzman, Alan ^a   Mo, Yin Yuan ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Notch signaling; Review; Tumorigenesis

Indexed keywords

NOTCH RECEPTOR;

BREAST TUMOR; CELL TRANSFORMATION; FEMALE; HUMAN; METABOLISM; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; PROGNOSIS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 34347240929     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2394     Document Type: Article

References (135)

1. Radtke, F. & K. Raj: The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer, 3, 756-67 (2003) (Pubitemid 37328814)
2. Callahan, R. & S. E. Egan: Notch signaling in mammary development and oncogenesis. J Mammary Gland Biol Neoplasia, 9, 145-63 (2004) (Pubitemid 39177500)
3. Shi, W. & A. L. Harris: Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials. J Mammary Gland Biol Neoplasia, 11, 41-52 (2006) (Pubitemid 44309188)
4. Sjolund, J., C. Manetopoulos, M. T. Stockhausen & H. Axelson: The Notch pathway in cancer: differentiation gone awry. Eur J Cancer, 41, 2620-9 (2005) (Pubitemid 41607552)
5. Leong, K. G. & A. Karsan: Recent insights into the role of Notch signaling in tumorigenesis. Blood, 107, 2223-33 (2006) (Pubitemid 43345539)
6. Miele, L.: Notch signaling. Clin Cancer Res, 12, 1074-9 (2006) (Pubitemid 43342494)
7. Blaumueller, C. M., H. Qi, P. Zagouras & S. Artavanis-Tsakonas: Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane. Cell, 90, 281-91 (1997) (Pubitemid 27329713)
8. Logeat, F., C. Bessia, C. Brou, O. LeBail, S. Jarriault, N. G. Seidah & A. Israel: The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc Natl Acad Sci U S A, 95, 8108-12 (1998) (Pubitemid 28326074)
9. Fleming, R. J.: Structural conservation of Notch receptors and ligands. Semin Cell Dev Biol, 9, 599-607 (1998) (Pubitemid 128647240)
10. Brou, C., F. Logeat, N. Gupta, C. Bessia, O. LeBail, J. R. Doedens, A. Cumano, P. Roux, R. A. Black & A. Israel: A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell, 5, 207-16 (2000) (Pubitemid 30628080)
11. Mumm, J. S., E. H. Schroeter, M. T. Saxena, A. Griesemer, X. Tian, D. J. Pan, W. J. Ray & R. Kopan: A ligand-induced extracellular cleavage regulates gammasecretase-like proteolytic activation of Notch1. Mol Cell, 5, 197-206 (2000) (Pubitemid 30628079)
12. Hsieh, J. J., S. Zhou, L. Chen, D. B. Young & S. D. Hayward: CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex. Proc Natl Acad Sci U S A, 96, 23-8 (1999) (Pubitemid 29036046)
13. Jarriault, S., C. Brou, F. Logeat, E. H. Schroeter, R. Kopan & A. Israel: Signalling downstream of activated mammalian Notch. Nature, 377, 355-8 (1995)
14. Kao, H. Y., P. Ordentlich, N. Koyano-Nakagawa, Z. Tang, M. Downes, C. R. Kintner, R. M. Evans & T. Kadesch: A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev, 12, 2269-77 (1998) (Pubitemid 28371348)
15. Wu, L. & J. D. Griffin: Modulation of Notch signaling by mastermind-like (MAML) transcriptional co-activators and their involvement in tumorigenesis. Semin Cancer Biol, 14, 348-56 (2004) (Pubitemid 38993636)
16. Wu, L., J. C. Aster, S. C. Blacklow, R. Lake, S. Artavanis-Tsakonas & J. D. Griffin: MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat Genet, 26, 484-9 (2000)
17. Wu, L., T. Sun, K. Kobayashi, P. Gao & J. D. Griffin: Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors. Mol Cell Biol, 22, 7688-700 (2002)
18. Iso, T., L. Kedes & Y. Hamamori: HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol, 194, 237-55 (2003) (Pubitemid 36176887)
19. Kunnimalaiyaan, M., A. M. Vaccaro, M. A. Ndiaye & H. Chen: Over expression of the Notch1 intracellular domain (NICD) inhibits cellular proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells. J BiolChem (2006)
20. Ronchini, C. & A. J. Capobianco: Induction of cyclin D1 transcription and CDK2 activity by Notch (ic): implication for cell cycle disruption in transformation by Notch (ic). Mol Cell Biol, 21, 5925-34 (2001) (Pubitemid 32737809)
21. Weng, A. P., J. M. Millholland, Y. Yashiro-Ohtani, M. L. Arcangeli, A. Lau, C. Wai, C. Del Bianco, C. G. Rodriguez, H. Sai, J. Tobias, Y. Li, M. S. Wolfe, C. Shachaf, D. Felsher, S. C. Blacklow, W. S. Pear & J. C. Aster: c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev, 20, 2096-109 (2006) (Pubitemid 44157460)
22. Oswald, F., S. Liptay, G. Adler & R. M. Schmid: NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa. Mol Cell Biol, 18, 2077-88 (1998) (Pubitemid 28152657)
23. Dievart, A., N. Beaulieu & P. Jolicoeur: Involvement of Notch1 in the development of mouse mammary tumors. Oncogene, 18, 5973-81 (1999) (Pubitemid 29535009)
24. Chen, Y., W. H. Fischer & G. N. Gill: Regulation of the ERBB-2 promoter by RBPJkappa and NOTCH. J Biol Chem, 272, 14110-4 (1997) (Pubitemid 27232816)
25. Artavanis-Tsakonas, S., M. D. Rand & R. J. Lake: Notch signaling: cell fate control and signal integration in development. Science, 284, 770-6 (1999) (Pubitemid 29291335)
26. Ellisen, L. W., J. Bird, D. C. West, A. L. Soreng, T. C. Reynolds, S. D. Smith & J. Sklar: TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell, 66, 649-61 (1991) (Pubitemid 121001701)
27. Weng, A. P., A. A. Ferrando, W. Lee, J. P. t. Morris, L. B. Silverman, C. Sanchez-Irizarry, S. C. Blacklow, A. T. Look & J. C. Aster: Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science, 306, 269-71 (2004) (Pubitemid 39336870)
28. Hu, C., A. Dievart, M. Lupien, E. Calvo, G. Tremblay & P. Jolicoeur: Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors. Am J Pathol, 168, 973-90 (2006) (Pubitemid 43327749)
29. Jhappan, C., D. Gallahan, C. Stahle, E. Chu, G. H. Smith, G. Merlino & R. Callahan: Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev, 6, 345-55 (1992)
30. Gallahan, D., C. Jhappan, G. Robinson, L. Hennighausen, R. Sharp, E. Kordon, R. Callahan, G. Merlino & G. H. Smith: Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Cancer Res, 56, 1775-85 (1996) (Pubitemid 26118213)
31. Robbins, J., B. J. Blondel, D. Gallahan & R. Callahan: Mouse mammary tumor gene int-3: a member of the notch gene family transforms mammary epithelial cells. J Virol, 66, 2594-9 (1992)
32. Uyttendaele, H., G. Marazzi, G. Wu, Q. Yan, D. Sassoon & J. Kitajewski: Notch4/int-3, a mammary protooncogene, is an endothelial cell-specific mammalian Notch gene. Development, 122, 2251-9 (1996) (Pubitemid 26235824)
33. Zagouras, P., S. Stifani, C. M. Blaumueller, M. L. Carcangiu & S. Artavanis-Tsakonas: Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc Natl Acad Sci U S A, 92, 6414-8 (1995)
34. Daniel, B., A. Rangarajan, G. Mukherjee, E. Vallikad & S. Krishna: The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J Gen Virol, 78(Pt 5), 1095-101 (1997) (Pubitemid 27207596)
35. Leethanakul, C., V. Patel, J. Gillespie, M. Pallente, J. F. Ensley, S. Koontongkaew, L. A. Liotta, M. Emmert-Buck & J. S. Gutkind: Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene, 19, 3220-4 (2000) (Pubitemid 30455935)
36. Suzuki, T., D. Aoki, N. Susumu, Y. Udagawa & S. Nozawa: Imbalanced expression of TAN-1 and human Notch4 in endometrial cancers. Int J Oncol, 17, 1131-9 (2000)
37. Jundt, F., I. Anagnostopoulos, R. Forster, S. Mathas, H. Stein & B. Dorken: Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood, 99, 3398-403 (2002) (Pubitemid 34525322)
38. Lan, K., T. Choudhuri, M. Murakami, D. A. Kuppers & E. S. Robertson: Intracellular activated Notch1 is critical for proliferation of Kaposi's sarcoma-associated herpesvirus-associated B-lymphoma cell lines in vitro. J Virol, 80, 6411-9 (2006) (Pubitemid 43927444)
39. Park, J. T., M. Li, K. Nakayama, T. L. Mao, B. Davidson, Z. Zhang, R. J. Kurman, C. G. Eberhart, M. Shih Ie & T. L. Wang: Notch3 gene amplification in ovarian cancer. Cancer Res, 66, 6312-8 (2006)
40. Dang, L., X. Fan, A. Chaudhry, M. Wang, N. Gaiano & C. G. Eberhart: Notch3 signaling initiates choroid plexus tumor formation. Oncogene, 25, 487-91 (2006) (Pubitemid 43117634)
41. Hopfer, O., D. Zwahlen, M. F. Fey & S. Aebi: The Notch pathway in ovarian carcinomas and adenomas. Br J Cancer, 93, 709-18 (2005) (Pubitemid 41486463)
42. Purow, B. W., R. M. Haque, M. W. Noel, Q. Su, M. J. Burdick, J. Lee, T. Sundaresan, S. Pastorino, J. K. Park, I. Mikolaenko, D. Maric, C. G. Eberhart & H. A. Fine: Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res, 65, 2353-63 (2005) (Pubitemid 40490146)
43. Jundt, F., K. S. Probsting, I. Anagnostopoulos, G. Muehlinghaus, M. Chatterjee, S. Mathas, R. C. Bargou, R. Manz, H. Stein & B. Dorken: Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. Blood, 103, 3511-5 (2004) (Pubitemid 38525685)
44. Tohda, S. & N. Nara: Expression of Notch1 and Jagged1 proteins in acute myeloid leukemia cells. Leuk Lymphoma, 42, 467-72 (2001) (Pubitemid 32725602)
45. Stockhausen, M. T., J. Sjolund & H. Axelson: Regulation of the Notch target gene Hes-1 by TGFalpha induced Ras/MAPK signaling in human neuroblastoma cells. Exp Cell Res, 310, 218-28 (2005) (Pubitemid 41398083)
46. Felli, M. P., A. Vacca, A. Calce, D. Bellavia, A. F. Campese, R. Grillo, M. Di Giovine, S. Checquolo, C. Talora, R. Palermo, G. Di Mario, L. Frati, A. Gulino & I. Screpanti: PKC theta mediates pre-TCR signaling and contributes to Notch3-induced T-cell leukemia. Oncogene, 24, 992-1000 (2005) (Pubitemid 40313876)
47. Balint, K., M. Xiao, C. C. Pinnix, A. Soma, I. Veres, I. Juhasz, E. J. Brown, A. J. Capobianco, M. Herlyn & Z. J. Liu: Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression. J Clin Invest, 115, 3166-76 (2005) (Pubitemid 41567581)
48. Masuda, S., K. Kumano, K. Shimizu, Y. Imai, M. Kurokawa, S. Ogawa, M. Miyagishi, K. Taira, H. Hirai & S. Chiba: Notch1 oncoprotein antagonizes TGF-beta/Smad-mediated cell growth suppression via sequestration of coactivator p300. Cancer Sci, 96, 274-82 (2005) (Pubitemid 40895075)
49. Hallahan, A. R., J. I. Pritchard, S. Hansen, M. Benson, J. Stoeck, B. A. Hatton, T. L. Russell, R. G. Ellenbogen, I. D. Bernstein, P. A. Beachy & J. M. Olson: The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Cancer Res, 64, 7794-800 (2004) (Pubitemid 39446912)
50. Stylianou, S., R. B. Clarke & K. Brennan: Aberrant activation of notch signaling in human breast cancer. Cancer Res, 66, 1517-25 (2006) (Pubitemid 43259933)
51. Wang, Z., Y. Zhang, Y. Li, S. Banerjee, J. Liao & F. H. Sarkar: Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer Ther, 5, 483-93 (2006)
52. Liu, Z. J., M. Xiao, K. Balint, K. S. Smalley, P. Brafford, R. Qiu, C. C. Pinnix, X. Li & M. Herlyn: Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. Cancer Res, 66, 4182-90 (2006)
53. Wang, Z., Y. Zhang, S. Banerjee, Y. Li & F. H. Sarkar: Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer, 106, 2503-13 (2006) (Pubitemid 43787677)
54. Beverly, L. J., D. W. Felsher & A. J. Capobianco: Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression. Cancer Res, 65, 7159-68 (2005) (Pubitemid 41161246)
55. Mungamuri, S. K., X. Yang, A. D. Thor & K. Somasundaram: Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53. Cancer Res, 66, 4715-24 (2006)
56. Li, J. L. & A. L. Harris: Notch signaling from tumor cells: a new mechanismofangiogenesis. Cancer Cell, 8, 1-3 (2005) (Pubitemid 40991807)
57. Bergers, G. & L. E. Benjamin: Tumorigenesis and the angiogenic switch. Nat RevCancer, 3, 401-10 (2003) (Pubitemid 37328844)
58. Liu, Z. J., T. Shirakawa, Y. Li, A. Soma, M. Oka, G. P. Dotto, R. M. Fairman, O. C. Velazquez & M. Herlyn: Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol, 23, 14-25 (2003) (Pubitemid 36008497)
59. Patel, N. S., J. L. Li, D. Generali, R. Poulsom, D. W. Cranston & A. L. Harris: Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res, 65, 8690-7 (2005) (Pubitemid 41377356)
60. Mailhos, C., U. Modlich, J. Lewis, A. Harris, R. Bicknell & D. Ish-Horowicz: Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation, 69, 135-44 (2001) (Pubitemid 33755062)
61. Zeng, Q., S. Li, D. B. Chepeha, T. J. Giordano, J. Li, H. Zhang, P. J. Polverini, J. Nor, J. Kitajewski & C. Y. Wang: Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell, 8, 13-23 (2005) (Pubitemid 40991811)
62. Wang, Z., S. Banerjee, Y. Li, K. M. Rahman, Y. Zhang & F. H. Sarkar: Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factorkappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res, 66, 2778-84 (2006)
63. Curran, S. & G. I. Murray: Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer, 36, 1621-30 (2000) (Pubitemid 30616366)
64. John, A. & G. Tuszynski: The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res, 7, 14-23 (2001) (Pubitemid 32591662)
65. Xiong, H. Q., J. L. Abbruzzese, E. Lin, L. Wang, L. Zheng & K. Xie: NF-kappaB activity blockade impairs the angiogenic potential of human pancreatic cancer cells. Int J Cancer, 108, 181-8 (2004) (Pubitemid 37541768)
66. Zeng, H., K. Datta, M. Neid, J. Li, S. Parangi & D. Mukhopadhyay: Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF/VEGF expression in a pancreatic carcinoma cell line. Biochem Biophys Res Commun, 302, 46-55 (2003) (Pubitemid 36268917)
67. Wang, Z., Y. Zhang, S. Banerjee, Y. Li & F. H. Sarkar: Inhibition of nuclear factor kappab activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells. Int J Cancer, 118, 1930-6 (2006)
68. Zimber-Strobl, U. & L. J. Strobl: EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. Semin Cancer Biol, 11, 423-34 (2001) (Pubitemid 33105021)
69. Strobl, L. J., H. Hofelmayr, G. Marschall, M. Brielmeier, G. W. Bornkamm & U. Zimber-Strobl: Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2. J Virol, 74, 1727-35 (2000) (Pubitemid 30434029)
70. Hsieh, J. J., T. Henkel, P. Salmon, E. Robey, M. G. Peterson & S. D. Hayward: Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol Cell Biol, 16, 952-9 (1996) (Pubitemid 26061666)
71. Hofelmayr, H., L. J. Strobl, G. Marschall, G. W. Bornkamm & U. Zimber-Strobl: Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells. J Virol, 75, 2033-40 (2001) (Pubitemid 32147542)
72. Gordadze, A. V., R. Peng, J. Tan, G. Liu, R. Sutton, B. Kempkes, G. W. Bornkamm & P. D. Ling: Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus. J Virol, 75, 5899-912 (2001) (Pubitemid 32553120)
73. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer & N. Munoz: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9 (1999) (Pubitemid 29406813)
74. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine & P. M. Howley: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63, 1129-36 (1990) (Pubitemid 120035062)
75. Dyson, N., P. M. Howley, K. Munger & E. Harlow: The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science, 243, 934-7 (1989) (Pubitemid 19066153)
76. Weijzen, S., A. Zlobin, M. Braid, L. Miele & W. M. Kast: HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation. J Cell Physiol, 194, 356-62 (2003) (Pubitemid 36176896)
77. Rangarajan, A., R. Syal, S. Selvarajah, O. Chakrabarti, A. Sarin & S. Krishna: Activated Notch1 signaling cooperates with papillomavirus oncogenes in transformation and generates resistance to apoptosis on matrix withdrawal through PKB/Akt. Virology, 286, 23-30 (2001) (Pubitemid 32675462)
78. Nair, P., K. Somasundaram & S. Krishna: Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB/Akt-dependent pathway. J Virol, 77, 7106-12 (2003) (Pubitemid 36666904)
79. Wang, X. D., C. C. Leow, J. Zha, Z. Tang, Z. Modrusan, F. Radtke, M. Aguet, F. J. de Sauvage & W. Q. Gao: Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation. Dev Biol, 290, 66-80 (2006) (Pubitemid 43083604)
80. Duan, L., J. Yao, X. Wu & M. Fan: Growth suppression induced by Notch1 activation involves Wnt-beta-catenin down-regulation in human tongue carcinoma cells. Biol Cell, 98, 479-90 (2006) (Pubitemid 44203907)
81. Talora, C., S. Cialfi, O. Segatto, S. Morrone, J. Kim Choi, L. Frati, G. Paolo Dotto, A. Gulino & I. Screpanti: Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathways. Exp Cell Res, 305, 343-54 (2005) (Pubitemid 40462545)
82. Talora, C., D. C. Sgroi, C. P. Crum & G. P. Dotto: Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. Genes Dev, 16, 2252-63 (2002) (Pubitemid 35013088)
83. Fan, X., I. Mikolaenko, I. Elhassan, X. Ni, Y. Wang, D. Ball, D. J. Brat, A. Perry & C. G. Eberhart: Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Res, 64, 7787-93 (2004) (Pubitemid 39446911)
84. Feinberg, A. P. & B. Tycko: The history of cancer epigenetics. Nat Rev Cancer, 4, 143-53 (2004) (Pubitemid 38198742)
85. Laird, P. W.: Cancer epigenetics. Hum Mol Genet, 14 Spec No 1, R65-76 (2005) (Pubitemid 40542622)
86. Ferres-Marco, D., I. Gutierrez-Garcia, D. M. Vallejo, J. Bolivar, F. J. Gutierrez-Avino & M. Dominguez: Epigenetic silencers and Notch collaborate to promote malignant tumours by Rb silencing. Nature, 439, 430-6 (2006) (Pubitemid 43152828)
87. Dominguez, M.: Interplay between Notch signaling and epigenetic silencers in cancer. Cancer Res, 66, 8931-4 (2006) (Pubitemid 44521106)
88. Malaney, S. & R. J. Daly: The ras signaling pathway in mammary tumorigenesis and metastasis. J Mammary Gland Biol Neoplasia, 6, 101-13 (2001) (Pubitemid 33640649)
89. Gohring, U. J., T. Schondorf, V. R. Kiecker, M. Becker, C. Kurbacher & A. Scharl: Immunohistochemical detection of H-ras protooncoprotein p21 indicates favorable prognosis in node-negative breast cancer patients. Tumour Biol, 20, 173-83 (1999) (Pubitemid 29287473)
90. Weijzen, S., P. Rizzo, M. Braid, R. Vaishnav, S. M. Jonkheer, A. Zlobin, B. A. Osborne, S. Gottipati, J. C. Aster, W. C. Hahn, M. Rudolf, K. Siziopikou, W. M. Kast & L. Miele: Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med, 8, 979-86 (2002) (Pubitemid 35033702)
91. Fitzgerald, K., A. Harrington & P. Leder: Ras pathway signals are required for notch-mediated oncogenesis. Oncogene, 19, 4191-8 (2000)
92. Haruki, N., K. S. Kawaguchi, S. Eichenberger, P. P. Massion, S. Olson, A. Gonzalez, D. P. Carbone & T. P. Dang: Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancers. Cancer Res, 65, 3555-61 (2005) (Pubitemid 40616330)
93. Kiaris, H., K. Politi, L. M. Grimm, M. Szabolcs, P. Fisher, A. Efstratiadis & S. Artavanis-Tsakonas: Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium. Am J Pathol, 165, 695-705 (2004) (Pubitemid 38971398)
94. Coussens, L., T. L. Yang-Feng, Y. C. Liao, E. Chen, A. Gray, J. McGrath, P. H. Seeburg, T. A. Libermann, J. Schlessinger, U. Francke & et al.: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science, 230, 1132-9 (1985) (Pubitemid 16169997)
95. Slamon, D. J., G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich & W. L. McGuire: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-82 (1987) (Pubitemid 17231334)
96. Slamon, D. J., W. Godolphin, L. A. Jones, J. A. Holt, S. G. Wong, D. E. Keith, W. J. Levin, S. G. Stuart, J. Udove, A. Ullrich & et al.: Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science, 244, 707-12 (1989) (Pubitemid 19147683)
97. Kraus, M. H., N. C. Popescu, S. C. Amsbaugh & C. R. King: Overexpression of the EGF receptor-related protooncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. Embo J, 6, 605-10 (1987)
98. Sun, Y., W. Lowther, K. Kato, C. Bianco, N. Kenney, L. Strizzi, D. Raafat, M. Hirota, N. I. Khan, S. Bargo, B. Jones, D. Salomon & R. Callahan: Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling. Oncogene, 24, 5365-74 (2005) (Pubitemid 43080106)
99. Blokzijl, A., C. Dahlqvist, E. Reissmann, A. Falk, A. Moliner, U. Lendahl & C. F. Ibanez: Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J Cell Biol, 163, 723-8 (2003) (Pubitemid 37517880)
100. Zavadil, J., L. Cermak, N. Soto-Nieves & E. P. Bottinger: Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. Embo J, 23, 1155-65 (2004) (Pubitemid 38436879)
101. Nusse, R., A. van Ooyen, D. Cox, Y. K. Fung & H. Varmus: Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature, 307, 131-6 (1984) (Pubitemid 14132897)
102. Callahan, R. & G. H. Smith: MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways. Oncogene, 19, 992-1001 (2000) (Pubitemid 30153782)
103. Tsukamoto, A. S., R. Grosschedl, R. C. Guzman, T. Parslow & H. E. Varmus: Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell, 55, 619-25 (1988)
104. Howe, L. R. & A. M. Brown: Wnt signaling and breast cancer. Cancer Biol Ther, 3, 36-41 (2004)
105. Ugolini, F., J. Adelaide, E. Charafe-Jauffret, C. Nguyen, J. Jacquemier, B. Jordan, D. Birnbaum & M. J. Pebusque: Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes. Oncogene, 18, 1903-10 (1999) (Pubitemid 29145858)
106. Ugolini, F., E. Charafe-Jauffret, V. J. Bardou, J. Geneix, J. Adelaide, F. Labat-Moleur, F. Penault-Llorca, M. Longy, J. Jacquemier, D. Birnbaum & M. J. Pebusque: WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene, 20, 5810-7 (2001) (Pubitemid 32937950)
107. Nagahata, T., T. Shimada, A. Harada, H. Nagai, M. Onda, S. Yokoyama, T. Shiba, E. Jin, O. Kawanami & M. Emi: Amplification, up-regulation and over-expression of DVL-1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers. Cancer Sci, 94, 515-8 (2003) (Pubitemid 36849715)
108. Polakis, P.: Wnt signaling and cancer. Genes Dev, 14, 1837-51 (2000) (Pubitemid 30639518)
109. Behrens, J., J. P. von Kries, M. Kuhl, L. Bruhn, D. Wedlich, R. Grosschedl & W. Birchmeier: Functional interaction of beta-catenin with the transcription factor LEF-1. Nature, 382, 638-42 (1996) (Pubitemid 26268958)
110. Ayyanan, A., G. Civenni, L. Ciarloni, C. Morel, N. Mueller, K. Lefort, A. Mandinova, W. Raffoul, M. Fiche, G. P. Dotto & C. Brisken: Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proc Natl Acad Sci U S A, 103, 3799-804 (2006) (Pubitemid 43376635)
111. Espinosa, L., J. Ingles-Esteve, C. Aguilera & A. Bigas: Phosphorylation by glycogen synthase kinase-3 beta down-regulates Notch activity, a link for Notch and Wnt pathways. J Biol Chem, 278, 32227-35 (2003) (Pubitemid 37048415)
112. Uyttendaele, H., J. V. Soriano, R. Montesano & J. Kitajewski: Notch4 and Wnt-1 proteins function to regulate branching morphogenesis of mammary epithelial cells in an opposing fashion. Dev Biol, 196, 204-17 (1998) (Pubitemid 28198847)
113. Harris, A. L.: Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer, 2, 38-47 (2002) (Pubitemid 37328806)
114. Jaakkola, P., D. R. Mole, Y. M. Tian, M. I. Wilson, J. Gielbert, S. J. Gaskell, A. Kriegsheim, H. F. Hebestreit, M. Mukherji, C. J. Schofield, P. H. Maxwell, C. W. Pugh & P. J. Ratcliffe: Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science, 292, 468-72 (2001) (Pubitemid 32335942)
115. Ivan, M., K. Kondo, H. Yang, W. Kim, J. Valiando, M. Ohh, A. Salic, J. M. Asara, W. S. Lane & W. G. Kaelin, Jr.: HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science, 292, 464-8 (2001) (Pubitemid 32335941)
116. Gustafsson, M. V., X. Zheng, T. Pereira, K. Gradin, S. Jin, J. Lundkvist, J. L. Ruas, L. Poellinger, U. Lendahl & M. Bondesson: Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell, 9, 617-28 (2005) (Pubitemid 41555144)
117. Jogi, A., I. Ora, H. Nilsson, A. Lindeheim, Y. Makino, L. Poellinger, H. Axelson & S. Pahlman: Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci U S A, 99, 7021-6 (2002) (Pubitemid 34526250)
118. Soares, R., G. Balogh, S. Guo, F. Gartner, J. Russo & F. Schmitt: Evidence for the notch signaling pathway on the role of estrogen in angiogenesis. Mol Endocrinol, 18, 2333-43 (2004) (Pubitemid 39215261)
119. Parr, C., G. Watkins & W. G. Jiang: The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. Int J Mol Med, 14, 779-86 (2004)
120. Reedijk, M., S. Odorcic, L. Chang, H. Zhang, N. Miller, D. R. McCready, G. Lockwood & S. E. Egan: Highlevel coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res, 65, 8530-7 (2005) (Pubitemid 41330622)
121. Pece, S., M. Serresi, E. Santolini, M. Capra, E. Hulleman, V. Galimberti, S. Zurrida, P. Maisonneuve, G. Viale & P. P. Di Fiore: Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol, 167, 215-21 (2004) (Pubitemid 39435065)
122. To, M. D., N. Gokgoz, T. G. Doyle, D. B. Donoviel, J. A. Knight, P. S. Hyslop, A. Bernstein & I. L. Andrulis: Functional characterization of novel presenilin-2 variants identified in human breast cancers. Oncogene, 25, 3557-64 (2006) (Pubitemid 43901677)
123. Miele, L., H. Miao & B. J. Nickoloff: NOTCH signaling as a novel cancer therapeutic target. Curr Cancer Drug Targets, 6, 313-23 (2006) (Pubitemid 43961866)
124. Curry, C. L., L. L. Reed, T. E. Golde, L. Miele, B. J. Nickoloff & K. E. Foreman: Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells. Oncogene, 24, 6333-44 (2005) (Pubitemid 41486467)
125. Paris, D., A. Quadros, N. Patel, A. DelleDonne, J. Humphrey & M. Mullan: Inhibition of angiogenesis and tumor growth by beta and gamma-secretase inhibitors. Eur J Pharmacol, 514, 1-15 (2005) (Pubitemid 40692758)
126. Ponti, D., A. Costa, N. Zaffaroni, G. Pratesi, G. Petrangolini, D. Coradini, S. Pilotti, M. A. Pierotti & M. G. Daidone: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res, 65, 5506-11 (2005) (Pubitemid 40911148)
127. Al-Hajj, M., M. W. Becker, M. Wicha, I. Weissman & M. F. Clarke: Therapeutic implications of cancer stem cells. Curr Opin Genet Dev, 14, 43-7 (2004) (Pubitemid 38167476)
128. Mishra, L., K. Shetty, Y. Tang, A. Stuart & S. W. Byers: The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer. Oncogene, 24, 5775-89 (2005) (Pubitemid 43086137)
129. Singh, S. K., I. D. Clarke, T. Hide & P. B. Dirks: Cancer stem cells in nervous system tumors. Oncogene, 23, 7267-73 (2004) (Pubitemid 39382160)
130. Katoh, Y. & M. Katoh: Hedgehog signaling pathway and gastrointestinal stem cell signaling network (review). Int J Mol Med, 18, 1019-23 (2006)
131. Liu, S., G. Dontu & M. S. Wicha: Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res, 7, 86-95 (2005) (Pubitemid 40704127)
132. van Es, J. H., M. E. van Gijn, O. Riccio, M. van den Born, M. Vooijs, H. Begthel, M. Cozijnsen, S. Robine, D. J. Winton, F. Radtke & H. Clevers: Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature, 435, 959-63 (2005) (Pubitemid 40896322)
133. Smith, G. H., D. Gallahan, F. Diella, C. Jhappan, G. Merlino & R. Callahan: Constitutive expression of a truncated INT3 gene in mouse mammary epithelium impairs differentiation and functional development. Cell Growth Differ, 6, 563-77 (1995)
134. Dontu, G., K. W. Jackson, E. McNicholas, M. J. Kawamura, W. M. Abdallah & M. S. Wicha: Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res, 6, R605-15 (2004)
135. Patrawala, L., T. Calhoun, R. Schneider-Broussard, J. Zhou, K. Claypool & D. G. Tang: Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2-cancer cells are similarly tumorigenic. Cancer Res, 65, 6207-19 (2005) (Pubitemid 40994406)